Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

TMK reduces capex

5/30/24 TRMK

Segezha Group released a trial batch of "green" coal

5/30/24 SGZH

Shareholders of Ryazan Energy Supply Company approved dividends for 2023

5/30/24 RZSB

Aeroflot reported for 3 months of 2024 by IFRS

5/30/24 AFLT

Shareholders of Zaymer approved dividends for 3 months 2024

5/30/24 ZAYM

First Monetka opened in the Republic of Tatarstan

5/30/24 LENT

Board of Directors of Element recommended that dividends be paid for 2023

5/30/24 ELMT

Inter RAO reported for 3 months of 2024 by IFRS

5/30/24 IRAO

Transneft reported for 3 months of 2024 by IFRS

5/30/24 TRNFP

Magnit reported for the 3 months of 2024 by RAS

5/30/24 MGNT